CrushSCI.com
Journal Selection & Manuscript Polishing Services
JOURNAL OF DERMATOLOGICAL TREATMENT journal cover Medicine
Back to journal directory

Review Cycle Records

JOURNAL OF DERMATOLOGICAL TREATMENT

Taylor & Francis SCIE OA
2026 Emerging Zone 32025 CAS Zone 42025 JCR Q1
100.4Average days
65Median days
2Fastest days
242Longest days
1932025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

146 days

The emerging applications of JAK inhibitors in dermatology – a systematic review

AuthorsKhalid M. A. Ahmed; Alaa I. Alnajdawi; Nithikka Senthil Kumar; Syeda Mashala Jan; Katharine L. Warburton

Affiliations1. Leeds Institute of Medical Education, University of Leeds; 2. School of Medicine, The University of Jordan; 3. School of Medicine, University of Leeds; 4. Leeds Centre of Dermatology, Leeds Teaching Hospitals NHS Trust

Source PDF DOI Publisher page
112 days

Use of topical treatment among Swedish children with eczema during the first 18 months of life

AuthorsMaja af Klinteberg; Bo Glas; Richard Lundberg-Ulfsdotter; Magnus Domellöf; Christina E. West

Affiliations1. Department of Public Health and Clinical Medicine, Dermatology and Venereology, Umeå University, Umea; 2. Department of Clinical Sciences, Pediatrics, Umeå University, Umea

Source PDF DOI Publisher page
36 days

Real-world effectiveness of abrocitinib and upadacitinib in atopic dermatitis: a propensity-matched analysis

AuthorsRuojun Wang; Zhihui Yang; Hang Li; Yang Wang

Affiliations1. Department of Dermatology, Peking University First Hospital; 2. National Clinical Research Center for Skin and Sexually Transmitted Diseases; 3. Research Center for Medical Mycology, Peking University

Source PDF DOI Publisher page
62 days

Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update

AuthorsMohammed Ibrahim Fatani; Yousef Binamer; Dana Alessa; Hajer Y. Almudaiheem; Mohammed Abdulaziz Alajlan; Issam Hamadah; Bedor A. Al-Omari; Fahad Alzuriqan; Haifa F. Alotaibi; Waleed Alhazzani; Ahmed Aljedai; Maysa Tariq Eshmawi

Affiliations1. Hera General Hospital; 2. Department of Dermatology, King Faisal Specialist Hospital & Research Center; 3. Colleges of Medicine and Pharmacy, Alfaisal University; 4. College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS); 5. King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard; 6. Division of Dermatology, Department of Medicine, King Abdulaziz Medical City (KAMC), National Guard Health Affairs (NGHA); 7. The Saudi Society of Clinical Pharmacy; 8. Dermatology Section, Medical Specialties Department, King Fahad Medical City; 9. Department of Pharmaceutical Care Services, Prince Sultan Military Medical City; 10. Drug Policy and Regulations, Ministry of Health; 11. Research and Innovation Institute, Ministry of Defense Health Services; 12. Department of Critical Care and Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University; 13. Department of Pharmacy Practice, Colleges of Medicine and Pharmacy, Alfaisal University; 14. Department of Dermatology, College of Medicine, Imam Mohammad Ibn Saud Islamic University; 15. Department of Dermatology, King Abdullah Medical Complex

Source PDF DOI Publisher page
230 days

Real-world clinical experience with ruxolitinib cream versus systemic therapies in patients with moderate atopic dermatitis in the United States

AuthorsJinan Liu; Oliver Howell; James Piercy; Peter Anderson; Daniel Sturm

Affiliations1. Incyte Corporation; 2. Adelphi Real World

Source PDF DOI Publisher page
118 days

Development of items to assess noticeability and sun sensitivity among patients with non-segmental vitiligo

AuthorsDavid Rosmarin; Ahmed M. Soliman; Dana DiBenedetti; Amy Greenblatt; Rohini Sen; Stavonnie Patterson; Khaled Ezzedine

Affiliations1. Department of Dermatology, Indiana University School of Medicine; 2. Department of Value and Evidence, AbbVie, Inc; 3. Department of Patient-Centered Outcomes Assessment, RTI Health Solutions; 4. Immunology Clinical Development, AbbVie, Inc; 5. Department of Dermatology, Multicultural Dermatology Center, Henry Ford Health

Source PDF DOI Publisher page
242 days

Use of narrowband-UVB phototherapy as long-term treatment of urticaria pigmentosa: a case series

AuthorsCarli Tucci; Zasca-Aisha Ristianto; Elisabeth G. Richard; John G. Zampella

Affiliations1. New York University Grossman School of Medicine; 2. Department of Dermatology, Johns Hopkins University School of Medicine; 3. The Ronald O. Perelman Department of Dermatology, New York University School of Medicine

Source PDF DOI Publisher page
43 days

Efficacy and safety of JAK inhibitors for vitiligo: an updated systematic review and meta-analysis of randomized controlled trials

AuthorsZiyi Lin; Yi Chen; Jingpeng Chen; Yongxiang Long; Changxia Xiong; Xingwu Duan; Chunxiao Bai; Guangshan Chen

Affiliations1. Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine; 2. Department of Orthopaedics, Dongzhimen Hospital, Beijing University of Chinese Medicine

Source PDF DOI Publisher page
2 days

Letter to editor regarding ‘Clinical predictors of early treatment response across systemic therapies in psoriasis: a prospective cohort study’

AuthorsDeep Shikha; Sunita Sharma

Affiliations1. Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation, Maharishi Markandeshwar University (Deemed to be University)

Source PDF DOI Publisher page
230 days

Dupilumab treatment improves signs, symptoms, and quality of life in children aged 6 months to 11 years with moderate-to-severe atopic dermatitis: a plain language summary

AuthorsElaine C. Siegfried; Michael J. Cork; Benjamin Lockshin; Norito Katoh; Wendy Smith Begolka; Ryan B. Thomas; Randy Prescilla

Affiliations1. Saint Louis University; 2. Cardinal Glennon Children’s Hospital; 3. Sheffield Dermatology Research, University of Sheffield Medical School; 4. Sheffield Children’s NIHR Commercial Research Delivery Centre; 5. U.S. Dermatology Partners; 6. Georgetown University; 7. Kyoto Prefectural University of Medicine Graduate School of Medical Science; 8. National Eczema Association; 9. Regeneron Pharmaceuticals Inc; 10. Sanofi

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.